Literature DB >> 20202089

Effects of long-term use of HAART on oral health status of HIV-infected subjects.

Wipawee Nittayananta1, Sineepat Talungchit, Sutep Jaruratanasirikul, Kachornsakdi Silpapojakul, Panthip Chayakul, Ampaipith Nilmanat, Nannapat Pruphetkaew.   

Abstract

BACKGROUND: The aim of this study was to determine the effects of long-term use of highly active antiretroviral therapy (HAART) on oral health status of HIV-infected subjects.
METHODS: Oral examination and measurement of saliva flow rate of both unstimulated and wax-stimulated whole saliva were performed in HIV-infected subjects with and without HAART, and in non-HIV individuals. The following data were recorded; duration and risk of HIV infection, type and duration of HAART, CD4 cell count, viral load, presence of orofacial pain, oral dryness, oral burning sensation, oral lesions, cervical caries, and periodontal pocket. Multiple logistic regression analysis was performed to determine the effects of long-term use of HAART on oral health status of HIV-infected subjects.
RESULTS: One hundred and fifty-seven HIV-infected subjects - 99 on HAART (age range 23-57 years, mean 39 years) and 58 not on HAART (age range 20-59 years, mean 34 years) - and 50 non-HIV controls (age range 19-59 years, mean 36 years) were enrolled. The most common HAART regimen was 2 NRTI + 2 NNRTI. HIV-infected subjects without HAART showed greater risks of having orofacial pain, oral dryness, oral lesions, and periodontal pockets than those with short-term HAART (P < 0.01). The subjects with long-term HAART were found to have a greater risk of having oral lesions than those with short-term HAART (P < 0.05). The unstimulated and stimulated salivary flow rates of the subjects with HAART were significantly lower than in those without HAART (P < 0.05).
CONCLUSION: We conclude that long-term HAART has adverse effects on oral health status of HIV-infected subjects.

Entities:  

Mesh:

Year:  2010        PMID: 20202089      PMCID: PMC3217232          DOI: 10.1111/j.1600-0714.2009.00875.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  65 in total

Review 1.  [Cutaneo-mucosal hyperpigmentation in AIDS. 4 cases].

Authors:  I Poizot-Martin; A Lafeuillade; C Dhiver; L Xeri; R Bouabdallah; T Gamby; J A Gastaut
Journal:  Presse Med       Date:  1991-04-13       Impact factor: 1.228

2.  Time to hit HIV, early and hard.

Authors:  D D Ho
Journal:  N Engl J Med       Date:  1995-08-17       Impact factor: 91.245

3.  Changes in the prevalence of HIV-associated mucosal disease at a dedicated clinic over 7 years.

Authors:  I Greenwood; J M Zakrzewska; P G Robinson
Journal:  Oral Dis       Date:  2002-03       Impact factor: 3.511

4.  Oral lesions in a group of Thai people with AIDS.

Authors:  W Nittayananta; S Chungpanich
Journal:  Oral Dis       Date:  1997-05       Impact factor: 3.511

5.  Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease.

Authors:  E M Race; J Adelson-Mitty; G R Kriegel; T F Barlam; K A Reimann; N L Letvin; A J Japour
Journal:  Lancet       Date:  1998-01-24       Impact factor: 79.321

6.  Oral manifestations of AIDS in a heterosexual population in a Zaire hospital.

Authors:  K Tukutuku; L Muyembe-Tamfum; K Kayembe; W Odio; K Kandi; M Ntumba
Journal:  J Oral Pathol Med       Date:  1990-05       Impact factor: 4.253

7.  Parotid enlargement in children seropositive for human immunodeficiency virus: imaging findings.

Authors:  N Soberman; J C Leonidas; W E Berdon; V Bonagura; J O Haller; M Posner; L Mandel
Journal:  AJR Am J Roentgenol       Date:  1991-09       Impact factor: 3.959

8.  Oral manifestations associated with HIV-related disease as markers for immune suppression and AIDS.

Authors:  M Glick; B C Muzyka; D Lurie; L M Salkin
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1994-04

9.  Oral conditions and their social impact among HIV dental patients.

Authors:  E Coates; G D Slade; A N Goss; E Gorkic
Journal:  Aust Dent J       Date:  1996-02       Impact factor: 2.291

10.  Oral lesions in Mexican HIV-infected patients.

Authors:  V Ramírez; A González; E de la Rosa; M González; I Rivera; C Hernández; S Ponce de León
Journal:  J Oral Pathol Med       Date:  1990-11       Impact factor: 4.253

View more
  43 in total

1.  Oral human β-defensin 2 in HIV-infected subjects with long-term use of antiretroviral therapy.

Authors:  Wipawee Nittayananta; Marisa Kemapunmanus; Korntip Amornthatree; Sineepat Talungchit; Hutcha Sriplung
Journal:  J Oral Pathol Med       Date:  2012-06-09       Impact factor: 4.253

Review 2.  Oral innate immunity in HIV infection in HAART era.

Authors:  Wipawee Nittayananta; Renchuan Tao; Lanlan Jiang; Yuanyuan Peng; Yuxiao Huang
Journal:  J Oral Pathol Med       Date:  2015-01-31       Impact factor: 4.253

3.  Triple Drug Combination of Zidovudine, Efavirenz and Lamivudine Loaded Lactoferrin Nanoparticles: an Effective Nano First-Line Regimen for HIV Therapy.

Authors:  Prashant Kumar; Yeruva Samrajya Lakshmi; Anand K Kondapi
Journal:  Pharm Res       Date:  2016-12-07       Impact factor: 4.200

4.  Effects of long-term use of antiretroviral therapy on the prevalence of oral Epstein-Barr virus.

Authors:  Korntip Amornthatree; Hutcha Sriplung; Winyou Mitarnun; Wipawee Nittayananta
Journal:  J Oral Pathol Med       Date:  2011-10-08       Impact factor: 4.253

5.  Comorbidities associated with HIV and antiretroviral therapy (clinical sciences): a workshop report.

Authors:  L T Vernon; Plp Jayashantha; M M Chidzonga; M C Komesu; R G Nair; N W Johnson
Journal:  Oral Dis       Date:  2016-04       Impact factor: 3.511

6.  Pseudomembranous Type of Oral Candidiasis is Associated with Decreased Salivary Flow Rate and Secretory Immunoglobulin A Levels.

Authors:  Bela Mahajan; Neeta Bagul; Rajiv Desai; Mamatha Reddy; Amit Mahajan; Ashwini Shete; Arun Risbud; Arati Mane
Journal:  Mycopathologia       Date:  2015-02-15       Impact factor: 2.574

Review 7.  Current trends and new developments in HIV research and periodontal diseases.

Authors:  Mark I Ryder; Caroline Shiboski; Tzy-Jyun Yao; Anna-Barbara Moscicki
Journal:  Periodontol 2000       Date:  2020-02       Impact factor: 7.589

Review 8.  Metabolic consequences of HIV: pathogenic insights.

Authors:  Amanda L Willig; E Turner Overton
Journal:  Curr HIV/AIDS Rep       Date:  2014-03       Impact factor: 5.071

9.  Anti-infective use in children and pregnancy: current deficiencies and future challenges.

Authors:  Amanda Gwee; Noel Cranswick
Journal:  Br J Clin Pharmacol       Date:  2015-02       Impact factor: 4.335

10.  Expression of oral cytokines in HIV-infected subjects with long-term use of antiretroviral therapy.

Authors:  W Nittayananta; K Amornthatree; M Kemapunmanus; S Talungchit; H Sriplung
Journal:  Oral Dis       Date:  2013-05-30       Impact factor: 3.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.